Related Herbs
Botanicals connected by the same goals, effects, or research topics.
Herb Profile
Dimocarpus longan
Longan (Dimocarpus longan) carries a Grade C rating — limited evidence.
Use extra caution — CNS active potential; avoid stacking with sedatives, alcohol, sleep aids, antidepressants, or other psychoactive supplements without clinician review. Details
Continue reading
Safety
CNS active potential; avoid stacking with sedatives, alcohol, sleep aids, antidepressants, or other psychoactive supplements without clinician review. Avoid pregnancy/breastfeeding use unless supervised.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Evidence-based safety
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Sedation / CNS depression
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 68 of 68 pairings in this mechanism group.
+56 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Read as directional context, not settled clinical proof.
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Oxidative Stress Modulation · Stress Response Modulation
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — CNS active potential; avoid stacking with sedatives, alcohol, sleep aids, antidepressants, or other psychoactive supplements without clinician review.
This profile cites 3 human studies.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Filter by study class
Showing 5 of 5 studies.
What the evidence actually shows
This table contains 5 structured sources, including 0 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Recent chemical synthesis of plant polysaccharides Wang X et al. · Curr Opin Chem Biol · 2023 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Zhu XR et al. · J Zhejiang Univ Sci B · 2019 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | A 2025 comprehensive review defines Longan Arillus as the fruit aril and catalogues 378 identified compounds, with polysaccharides and polyphenols emphasized. The review also concludes that in-vivo and clinical studies remain relatively limited, so broad pharmacologic activity should not be presented as established human benefit. | PubMed → |
Background | In-vitro research Studies cells, tissues, or biochemical systems outside a living person. It is preclinical evidence, not proof of a human outcome. | — | — | — | — | — | A 2025 study reported sleep-related enzyme/pathway effects in cell models using longan flower ethanol extract. It is not human sleep evidence and is plant-part specific, so it should be labeled mechanistic/preclinical rather than a clinical benefit. | PubMed → |
Chen Y et al. · Plant Physiol · 2023 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Longan Works
Key constituents studied in Longan, with full pharmacology and safety profiles.
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Compare side-by-side tradeoffs or verify active marker guidelines.
Continue comparing
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.